• Adjunct Associate Professor, Internal Medicine
  • Adjunct Assistant Professor, Population Health Sciences


  • English, Fluent.

Geographical Regions of Interest

  • United States
    Utah, Colorado.


  • Colonna S, Gammon A (date unknown). Management of the Patient with a Genetic Predisposition for Breast Cancer. Springer International Publishing. Accepted, .
  • Moody EW, Vagher J, Espinel W, Goldgar D, Hagerty KJ, Gammon A (date unknown). Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer Genes. Vol. 3, 1-8. Accepted, .
  • Steffen LE, Du R, Gammon A, Mandelblatt JS, Kohlmann WK, Lee JH, Buys SS, Stroup AM, Campo RA, Flores KG, Vicuña B, Schwartz MD, Kinney AY (date unknown). Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode. Vol. 26, 1772-1780. Accepted, .
  • Gammon A, Jasperson K, Pilarski R, Prior T, Kuwada S (date unknown). PTEN mosaicism with features of Cowden syndrome. Vol. 84, 593-5. Accepted, .
  • Gammon AD, Rothwell E, Simmons R, Lowery JT, Ballinger L, Hill DA, Boucher KM, Kinney AY (date unknown). Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer. Vol. 20, 625-38. Accepted, .
  • Chavez-Yenter D, Kimball KE, Kohlmann W, Lorenz Chambers R, Bradshaw RL, Espinel WF, Flynn M, Gammon A, Goldberg E, Hagerty KJ, Hess R, Kessler C, Monahan R, Temares D, Tobik K, Mann DM, Kawamoto K, Del Fiol G, Buys SS, Ginsburg O, Kaphingst KA (date unknown). Patient Interactions With an Automated Conversational Agent Delivering Pretest Genetics Education: Descriptive Study. Vol. 23, e29447. Accepted, .
  • Kinney AY, Butler KM, Schwartz MD, Mandelblatt JS, Boucher KM, Pappas LM, Gammon A, Kohlmann W, Edwards SL, Stroup AM, Buys SS, Flores KG, Campo RA (date unknown). Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. Vol. 106. Accepted, .
  • Greenberg S, Buys SS, Edwards SL, Espinel W, Fraser A, Gammon A, Hafen B, Herget KA, Kohlmann W, Roundy C, Sweeney C (date unknown). Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing. Vol. 8, 6789-6798. Accepted, .
  • Jasperson KW, Kanth P, Kirchhoff AC, Huismann D, Gammon A, Kohlmann W, Burt RW, Samadder NJ (date unknown). Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Vol. 56, 1211-6. Accepted, .
  • Patel J, Madan A, Gammon A, Sossenheimer M, Samadder NJ (date unknown). Rare hereditary cause of chronic pancreatitis in a young male: SPINK1 mutation. Vol. 28, 110. Accepted, .
  • Himes DO, Gibbons DK, Birmingham WC, Beckstrand RL, Gammon A, Kinney AY, Clayton MF (date unknown). Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands. Vol. 28, 950-961. Accepted, .
  • Himes D, Root A, Gammon A, Luthy K (date unknown). Breast Cancer Risk Assessment: Calculating Lifetime Risk Using the Tyrer-Cuzick Model. Vol. 12, 581-592. Accepted, .
  • Gammon A, Neklason DW (date unknown). Confidentiality & the Risk of Genetic Discrimination: What Surgeons Need to Know. Vol. 24, 667-81. Accepted, .
  • Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, Gammon A, Butler K, Buys SS, Stroup AM, Campo RA, Flores KG, Mandelblatt JS, Schwartz MD (date unknown). Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up. Vol. 34, 2914-24. Accepted, .
  • Wain KE, Ellingson MS, McDonald J, Gammon A, Roberts M, Pichurin P, Winship I, Riegert-Johnson DL, Weitzel JN, Lindor NM (date unknown). Appreciating the broad clinical features of SMAD4 mutation carriers: a multicenter chart review. Vol. 16, 588-93. Accepted, .
  • Gammon A, Jasperson K, Champine M (date unknown). Genetic basis of Cowden syndrome and its implications for clinical practice and risk management. Vol. 9, 83-92. Accepted, .
  • Young EL, Thompson BA, Neklason DW, Firpo MA, Werner T, Bell R, Berger J, Fraser A, Gammon A, Koptiuch C, Kohlmann WK, Neumayer L, Goldgar DE, Mulvihill SJ, Cannon-Albright LA, Tavtigian SV (date unknown). Pancreatic cancer as a sentinel for hereditary cancer predisposition. Vol. 18, 697. Accepted, .
  • Kaphingst KA, Kohlmann W, Chambers RL, Goodman MS, Bradshaw R, Chan PA, Chavez-Yenter D, Colonna SV, Espinel WF, Everett JN, Gammon A, Goldberg ER, Gonzalez J, Hagerty KJ, Hess R, Kehoe K, Kessler C, Kimball KE, Loomis S, Martinez TR, Monahan R, Schiffman JD, Temares D, Tobik K, Wetter DW, Mann DM, Kawamoto K, Del Fiol G, Buys SS, Ginsburg O, BRIDGE research team. (date unknown). Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial. Vol. 21, 542. Accepted, .
  • Flores KG, Steffen LE, McLouth CJ, Vicuña BE, Gammon A, Kohlmann W, Vigil L, Dayao ZR, Royce ME, Kinney AY (date unknown). Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families. Vol. 26, 480-490. Accepted, .
  • Young EL, Feng BJ, Stark AW, Damiola F, Durand G, Forey N, Francy TC, Gammon A, Kohlmann WK, Kaphingst KA, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette AM, Pertesi M, Robinot N, Rosenthal JS, Vallee M, Voegele C, Hopper JL, Southey MC, Andrulis IL, John EM, Hashibe M, Gertz J, Breast Cancer Family Registry., Le Calvez-Kelm F, Lesueur F, Goldgar DE, Tavtigian SV (date unknown). Multigene testing of moderate-risk genes: be mindful of the missense. Vol. 53, 366-76. Accepted, .
  • Jasperson KW, Kohlmann W, Gammon A, Slack H, Buchmann L, Hunt J, Kirchhoff AC, Baskin H, Shaaban A, Schiffman JD (date unknown). Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families. Vol. 13, 257-65. Accepted, .
  • Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, Sharma L, Saam J, Lancaster J, Daly MB (date unknown). A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Vol. 123, 1721-1730. Accepted, .
  • Rothwell E, Kohlmann W, Jasperson K, Gammon A, Wong B, Kinney A (date unknown). Patient outcomes associated with group and individual genetic counseling formats. Vol. 11, 97-106. Accepted, .
  • Nick HP, Kehoe K, Gammon A, Contreras JL, Kaphingst KA (date unknown). Researcher Knowledge, Attitudes, and Communication Practices for Genomic Data Sharing. Vol. 16, 125-137. Accepted, .
  • Kinney AY, Gammon A, Coxworth J, Simonsen SE, Arce-Laretta M (date unknown). Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Vol. 12, 105-15. Accepted, .
  • Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS, Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS (date unknown). Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas. Vol. 12, 59, e1-13. Accepted, .
  • Anderson AE, Flores KG, Boonyasiriwat W, Gammon A, Kohlmann W, Birmingham WC, Schwartz MD, Samadder J, Boucher K, Kinney AY (date unknown). Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk. Vol. 17, 48-60. Accepted, .
  • Vallée MP, Francy TC, Judkins MK, Babikyan D, Lesueur F, Gammon A, Goldgar DE, Couch FJ, Tavtigian SV (date unknown). Classification of missense substitutions in the BRCA genes: a database dedicated to Ex-UVs. Vol. 33, 22-8. Accepted, .
  • Gammon A, Jasperson K, Kohlmann W, Burt RW (date unknown). Hamartomatous polyposis syndromes. Vol. 23, 219-31. Accepted, .
  • Gammon A, Kohlmann W, Burt R (date unknown). Can we identify the high-risk patients to be screened? A genetic approach. Vol. 76, 7-19. Accepted, .
  • Vagher J, Gammon A, Kohlmann W, Jeter J (date unknown). Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders. (pp. 837059). Vol. 12. Accepted, .